Tatva Chintan Pharma Chem Ltd. IPO
Tatva Chintan Pharma Chem Ltd.
IPO Listing Details
Listed On
BSE & NSE
Listed On
Issue Price
₹1,083
Issue Price
Listing Price
₹2,112
Listing Price
Listing Gains
+₹1028.80 (+95.00%)
Listing Gains
IPO Details
Bidding Dates
16 Jul - 20 Jul '21
Bidding Dates
Min. Investment
₹13,949
Min. Investment
Lot Size
13.00
Lot Size
Price Range
₹1073 - ₹1083
Price Range
Issue Size
495 Cr
Issue Size
Subscription Rate
- Retail Individual Investor35.34x
- Non-Institutional Investor512.22x
- Qualified Institutional Buyers185.23x
- Employees0.00x
About Company
Tatva Chintan manufactures speciality chemicals like structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts, pharmaceutical and agrochemical intermediates.
They serve customers across industries like petroleum, pharmaceutical, agro-chemicals, automotive, paints, coatings and personal care to name a few.
Apart from supplying the domestic market, they also export products to more than 25 countries including the US, UK, China and Japan.
Tatva Chintan Pharma Chem Ltd. IPO Latest News and Subscription Status Today (Live)
Out of Rs. 500 crore issue size, upto Rs. 225 crore was fresh issue whereas balance upto Rs. 275 crore was offer for sale of equity shares.
The company is planning to utilise the amount raised through IPO for capital expenditure at two of its facilities and the balance to meet general corporate requirements.
Why should you invest in Tatva Chintan Pharma Chem Ltd. IPO?
Tatva Chintan is a leader amongst SDA and PTC manufacturers. They have a monopoly in manufacturing SDAs for zeolites in India and even globally, they stand second position. They strive to maintain the high-quality of their products. More than 70% of their revenue comes from exports. These factors ensure consistent growth in the industry.
Tatva Chintan Pharma Chem Ltd. IPO - SWOT Analysis
Strengths:
They enjoy a monopoly in India by being the only manufacturer of SDAs for zeolites. Significant revenue comes from exports to countries like the US, UK, China, South Africa and Japan. Their varied product line for industries like automotive, agrochemicals, pharmaceuticals, petroleum, etc., gives them sufficient diversity.
Weaknesses:
Tatva Chintan is dependent on limited raw material suppliers, which also exposes them to cost fluctuations. If timely delivery of required raw materials is not available, it can affect the quality standard of their products.
Opportunities:
They stand in the second position globally in manufacturing SDAs for zeolites. This gives Tatva Chintan a lot of scope to expand in global markets and serve additional industries.
Threats:
Outbreaks of pandemics like COVID 19 and global lockdown or slowdown have a major impact on the company. Change of international economic policies and trade agreements between countries can majorly impact the export revenue.
How to apply for Tatva Chintan Pharma Chem Ltd. IPO?
You can apply for the Tatva Chintan Pharma Chem Ltd. IPO in these ways:
UPI
Link your personal bank A/C to a trusted UPI ID and map it with your TradeSmart account. Now, proceed further to book your IPO. On acceptance of the mandate, the bid amount will get blocked in your bank account Learn more.
Demat Account
1. If you are an Existing TradeSmart demat account holder and wish to apply for an Tatva Chintan Pharma Chem Ltd. click here.
2. If you don't have a TradeSmart Account? Sign up.
